Mutant huntingtin's effects on striatal gene expression in mice recapitulate changes observed in human Huntington's disease brain and do not differ with mutant huntingtin length or wild-type huntingtin dosage

By Kuhn Alexandre   Goldstein Darlene R.   Hodges Angela   Strand Andrew D.   Sengstag Thierry   Kooperberg Charles   Becanovic Kristina   Pouladi Mahmoud A.   Sathasivam Kirupa   Cha Jang-Ho J.   Hannan Anthony J.   Hayden Michael R.   Leavitt Blair R.   Dunnett Stephen B.   Ferrante Robert J.   Albin Roger   Shelbourne Peggy   Delorenzi Mauro   Augood Sarah J.   Faull Richard L.M.   Olson James M.   Bates Gillian P.   Jones Lesley   Luthi-Carter Ruth  

Human Molecular Genetics, Vol. 16, Iss. 15, 2007-08 ,pp. : 1845-1861

Oxford University Press

Access to resources Recommend Favorite

Increased huntingtin protein length reduces the number of polyglutamine-induced gene expression changes in mouse models of Huntington's disease

By Chan Edmond Y.W.  

Human Molecular Genetics, Vol. 11, Iss. 17, 2002-06 ,pp. : 1939-1951

Oxford University Press

Access to resources Recommend Favorite

Polyglutamine and transcription: gene expression changes shared by DRPLA and Huntington's disease mouse models reveal context-independent effects

By Borchelt D.R.  

Human Molecular Genetics, Vol. 11, Iss. 17, 2002-06 ,pp. : 1927-1937

Oxford University Press

Access to resources Recommend Favorite

Polyglutamine expansions cause decreased CRE-mediated transcription and early gene expression changes prior to cell death in an inducible cell model of Huntington’s disease

By Schapira A.  

Human Molecular Genetics, Vol. 10, Iss. 17, 2001-08 ,pp. : 1829-1845

Oxford University Press

Access to resources Recommend Favorite

Gene expression in Huntington's disease skeletal muscle: a potential biomarker

By Strand Andrew D.  

Human Molecular Genetics, Vol. 14, Iss. 13, 2005-07 ,pp. : 1863-1876

Oxford University Press

Access to resources Recommend Favorite